California Presses Forward In Fight To Regulate Pharma
Such efforts have previously failed in the face of opposition from the drug industry, which questions their effectiveness and contends prices reflect research and development costs.
The independent source for health policy research, polling, and news.
2,581 - 2,600 of 3,970 Results
Such efforts have previously failed in the face of opposition from the drug industry, which questions their effectiveness and contends prices reflect research and development costs.
Amplifying the "patient voice," those with the rarest afflictions are trained to become powerful advocates for new drugs and legislation that would help the industry.
There are many ways beyond legislative repeal for the Trump administration and congressional Republicans to unravel the Affordable Care Act.
After the collapse of the Republican replacement plan, there may be a way to find consensus and repair the law.
The changes proposed by the administration for the health law marketplaces in 2018 could increase customers鈥 out-of-pocket costs and reduce the amount they receive in premium tax credits.
The medical supply industry makes a particularly revelatory case study of the difficulties of untangling global trade.
With high-level connections in the Capitol, Parker "Pete" Petit aims to resolve regulatory issues that have haunted his wound care company.
They want the state鈥檚 new tobacco tax to help pay for a raise in Medicaid rates, but so far Gov. Jerry Brown has other plans for that money.
Democratic senators want the Justice Department to reveal what it knows about ProPublica鈥檚 recent report that HHS Secretary Tom Price鈥檚 stock trades were under investigation by former U.S. Attorney Preet Bharara before the Trump administration fired him.
Some urologists use March Madness as an opportunity to market vasectomy services, offering men the excuse to sit on the sofa for three days to watch college basketball while they recover.
The Department of Justice is joining a whistleblower lawsuit in a fraud case against UnitedHealth in which damages could top $1 billion.
As Congress and the White House try to strike a bargain on an Obamacare repeal plan, the insurance industry likes what it鈥檚 seeing.
Republicans and Democrats don鈥檛 agree on much these days, but both parties want to keep the health law鈥檚 provision to allow adults to stay on their parents鈥 plan until age 26. But that could be hurting the marketplace鈥檚 insurance pools.
The Government Accountability Office said it will investigate potential abuses of the orphan drug program, which offers incentives to drugmakers to develop medicines for rare diseases.
The legislation, passed by the House, would allow nationwide 鈥渁ssociation health plans.鈥 But consumer advocates have raised serious concerns about such options in the past.
Is Republican Rep. Mark Meadows the man who would kill "Trumpcare"? He enjoys strong support in his gerrymandered western North Carolina district as he leads conservative opposition to the GOP鈥檚 plan for repealing and replacing Obamacare.
Lesser-known provisions in the Republican proposal to replace the Affordable Care Act would push some Medicaid enrollees out of coverage and cause financial pain for others.
Spending on consumer advertising by drugmakers has increased 62 percent since 2012.
Matching with a residency program had an added layer of stress this year for doctors-in-training from the countries affected by President Donald Trump's travel ban.
The HHS Secretary bought stock in companies that stood to benefit from legislation he voted for and sponsored as a Georgia congressman.
漏 2026 51视频